BACKGROUND: Prostate cancer arises in the transition zone (TZ) in approximately 20-25% of cases. Modern biopsy and surveillance protocols, and advances in prostate cancer imaging, have renewed interest in TZ prostate cancers. We compared TZ and PZ prostate cancer to determine if cancer location is independently associated with better outcomes. METHODS: We evaluated an expanded cohort of 1354 men who underwent radical prostatectomy between 1983 and 2003 with updated long-term clinical follow-up. Regression models were used to compare the volume of high-grade (Gleason 4 or 5) cancer and total cancer volume by location. Uni- and multi-variable logistic regression models tested the associations between cancer location and adverse pathologic features. Multivariable proportional hazard models were fit to examine cancer recurrence. RESULTS: Patients with TZ cancer presented with higher pre-operative serum PSA values (11.07 vs. 7.86 ng/ml) and larger total cancer volume (7.1 vs. 3.8 cc). Patients with TZ cancer had decreased odds of seminal vesicle invasion (OR 0.08, 95% CI 0.03, 0.21), extra-capsular extension (OR 0.56, 95% CI 0.35, 0.92), and lymphovascular invasion (OR 0.48, 95% CI 0.27, 0.87) in multivariable models. TZ cancers were independently associated with decreased hazard of tumor recurrence (HR 0.62, 95% CI 0.43, 0.90). CONCLUSIONS: TZ cancer prostate is associated with favorable pathologic features and better recurrence-free survival despite being diagnosed with larger cancers and higher PSA values. Tumor location should be taken into account when stratifying patient risk before and after prostatectomy, particularly with the evolving role of imaging in prostate cancer management.
BACKGROUND:Prostate cancer arises in the transition zone (TZ) in approximately 20-25% of cases. Modern biopsy and surveillance protocols, and advances in prostate cancer imaging, have renewed interest in TZ prostate cancers. We compared TZ and PZ prostate cancer to determine if cancer location is independently associated with better outcomes. METHODS: We evaluated an expanded cohort of 1354 men who underwent radical prostatectomy between 1983 and 2003 with updated long-term clinical follow-up. Regression models were used to compare the volume of high-grade (Gleason 4 or 5) cancer and total cancer volume by location. Uni- and multi-variable logistic regression models tested the associations between cancer location and adverse pathologic features. Multivariable proportional hazard models were fit to examine cancer recurrence. RESULTS:Patients with TZcancer presented with higher pre-operative serum PSA values (11.07 vs. 7.86 ng/ml) and larger total cancer volume (7.1 vs. 3.8 cc). Patients with TZcancer had decreased odds of seminal vesicle invasion (OR 0.08, 95% CI 0.03, 0.21), extra-capsular extension (OR 0.56, 95% CI 0.35, 0.92), and lymphovascular invasion (OR 0.48, 95% CI 0.27, 0.87) in multivariable models. TZcancers were independently associated with decreased hazard of tumor recurrence (HR 0.62, 95% CI 0.43, 0.90). CONCLUSIONS:TZcancer prostate is associated with favorable pathologic features and better recurrence-free survival despite being diagnosed with larger cancers and higher PSA values. Tumor location should be taken into account when stratifying patient risk before and after prostatectomy, particularly with the evolving role of imaging in prostate cancer management.
Authors: Sara M Falzarano; Maria Navas; Kelly Simmerman; Eric A Klein; Mark A Rubin; Ming Zhou; Cristina Magi-Galluzzi Journal: Mod Pathol Date: 2010-08-06 Impact factor: 7.842
Authors: Lih-Ming Wong; Ants Toi; Theodorus Van der Kwast; Greg Trottier; Shabbir M H Alibhai; Narhari Timilshina; Andrew Evans; Alexandre Zlotta; Neil Fleshner; Antonio Finelli Journal: J Urol Date: 2014-04-15 Impact factor: 7.450
Authors: Irina V Kovtun; John C Cheville; Stephen J Murphy; Sarah H Johnson; Shabnam Zarei; Farhad Kosari; William R Sukov; R Jeffrey Karnes; George Vasmatzis Journal: Cancer Res Date: 2013-05-21 Impact factor: 12.701
Authors: Taimoor Khalid Janjua; Muhammad Ali Yousuf; Muhammad Talha Iqbal; Shahbaz Mustafa Memon; Aziz Abdullah; Naveen Faridi; Muhammad Irfan Journal: Pan Afr Med J Date: 2021-05-07
Authors: Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena Journal: Nat Rev Urol Date: 2021-10-19 Impact factor: 14.432
Authors: Nazanin Hajarol Asvadi; Sohrab Afshari Mirak; Amirhossein Mohammadian Bajgiran; Pooria Khoshnoodi; Pornphan Wibulpolprasert; Daniel Margolis; Anthony Sisk; Robert E Reiter; Steven S Raman Journal: Abdom Radiol (NY) Date: 2018-11
Authors: Jorge Abreu-Gomez; Daniel Walker; Tareq Alotaibi; Matthew D F McInnes; Trevor A Flood; Nicola Schieda Journal: Eur Radiol Date: 2020-03-24 Impact factor: 5.315
Authors: James D Brooks; Wei Wei; Sarah Hawley; Heidi Auman; Lisa Newcomb; Hilary Boyer; Ladan Fazli; Jeff Simko; Antonio Hurtado-Coll; Dean A Troyer; Peter R Carroll; Martin Gleave; Raymond Lance; Daniel W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; Ziding Feng; Jesse K McKenney Journal: PLoS One Date: 2015-07-14 Impact factor: 3.240
Authors: Elisabeth A Messner; Thomas M Steele; Maria Malvina Tsamouri; Nazila Hejazi; Allen C Gao; Maria Mudryj; Paramita M Ghosh Journal: Biomedicines Date: 2020-10-15
Authors: Pranav Satish; Alex Freeman; Daniel Kelly; Alex Kirkham; Clement Orczyk; Benjamin S Simpson; Francesco Giganti; Hayley C Whitaker; Mark Emberton; Joseph M Norris Journal: BMJ Open Date: 2022-01-05 Impact factor: 2.692